In September, the EASD held its annual meeting in Lisbon. For those not present, presentations can be seen at http://www.easdvirtualmeeting.org/. As in previous years, PSAD members presented their work during paper and poster session, and the PSAD itself was present with a booth. Despite these activities, visibility of psychosocial research at the annual EASD meeting remains very limited indeed. Therefore, I was pleased that the PSAD was invited to submit a symposium suggestion for the 2018 EASD Berlin meeting.

In response to this invitation, we asked you for suggestions. We received eight proposals, which roughly fell into three categories: depression/diabetes distress, translation of psychosocial findings to clinical practice, psychosocial aspects of new technologies. Applying the following criteria (i. topic interesting to the majority of EASD participants – mainly diabetologists; ii. novelty aspects; iii. presenters mainly from the PSAD), the EC unanimously agreed that the proposal from Norbert Hermanns entitled ‘Use of novel technologies in diabetes and associated psychosocial care' ticked all the boxes and was submitted. We should hear shortly whether the proposal has been successful.

In further EASD news, at the Lisbon Study Group Forum meeting (the yearly meeting of all Study Groups with representatives of the EASD Executive), major changes were announced regarding the legal framework within which the Study Groups operate. This was in response to the discussions at the Munich Forum meeting where the Study Groups expressed the need for EASD support regarding bank accounts, registration, web presence, visibility and networking within the EASD.

More specifically, the proposed changes include:

1. Full administrative and legal support while maintaining continued scientific autonomy;

2. Updated EASD Statutes: each Study Groups will keep its own Steering Committee, but follow formal establishment or dissolution rules by the EASD Executive Committee and rules and procedures for daily functioning including a framework for scientific meetings, guidelines for publications, reporting requirements, membership and business ethics, etc. Note that much of this is already in existence, but it will be formalized with the EASD framework;

From the Chair

Autumn 2017

Newsletter

Inside this issue:

From the Chair p. 1

New Members p. 3

Members’Events p. 3

Highlighted

Publication

p.4

Announcement p.4

New Publications p.5

Grants and

Funding

p.8

PSAD Science

Award

p.9

PSAD Twitter

Account

p.9

PSAD Spring Meeting 2018

p.10

3. Opening of EASD bank accounts for each of the Study Groups with payments directly from the EASD Office. Study Groups will remain the sole beneficiaries of the funds in the accounts;

4. EASD support for the organization of Study Group meetings. For example, the EASD registration tool will be made available to the Study Groups. There will be direct consolidation with the bank accounts;

5. Increased visibility and networking: the Study Groups will be exhibiting at the EASD Community Plaza during the Annual meeting;

6. Websites of the Study Groups will be streamlined using a common template prepared by the EASD. While Study Groups will remain responsible for content input, maintenance and service will be provided by the EASD. Two email addresses @easd.org will be made available to each Study Group.

The proposed changes will become effective after approval by the 2018 EASD Assembly with

Page 2 PSAD Autumn 2017 Newsletter

estimated implementation to begin in February 2019.

Overall, it seems that the EASD Executive Committee has listened to the Study Groups and addressed many of the issues that were raised during the 2016 Forum meeting in Munich. The proposed changes seem to be a genuine attempt to improve the visibility and functioning of the Study Groups, specifically with regards to obtaining external funding. The devil is of course in the detail of the German legal system. Moreover, some unresolved issues remain such as how these changes can be made to fit the many different ways the Study Groups currently operate. The EASD estimates that theses changes will cost approximately €200k.

Finally, I am pleased to announce that the 2018 Spring Meeting will take place in Verona (Italy) from Thursday, 3rd May to Saturday, 5th May. The decision to change the start of the meeting from a Friday start to a Thursday was taken fol-lowing the discussion at the business meeting in Cluj. It should allow participants to have at least one day of the weekend with their family. Further details will be sent shortly.

Members’ Events

We would like to welcome our new members who recently

joined our group:

Tiziana Bufacchi— Clinical Psychologist and Psychotherapist,

Diabetes and Endocrinology. Princess Margaret Hospital for Children. Perth, Western Australia

Eva Graham— Ph.D. student, McGill University, Montreal, Canada, Douglas Mental Health University Institute, Montreal, Canada

Maged Hossameldin— M.B.,B.Ch /M.Sc, internal medicine resident, National Institute of Diabetes and Endocrinology, Cairo, Egypt

Niki Jehoel— Ph.D.student, Maastricht University, Department of Health Promotion, The Netherlands

Mette A Nexo— Ph.D., MA, Licensed psychologist, Researcher at Steno Diabetes Center Copenhagen, Denmark

Lisa Newson— Health Psychologist/ Sn Lecturer, Liverpool John Moores University, UK

Kimberley Smith— Ph.D., Lecturer in Health Psychology, Department of Psychology, University of

Surrey, UK

Stan Vluggen— Ph.D.-Candidate, School CAPHRI, Department of Health Promotion, Maastricht

University, The Netherlands

New Members

Page 3 PSAD Autumn 2017 Newsletter

From January 2017 Prof. Brianna Mezuk has moved to the University of Michigan School of Public

Health, USA.

Also, she is collaborating with Dr. Nao Hagiwara (Professor of Psychology at Virginia

Commonwealth University) on a new project funded by NIDDK to examine the role of non-verbal

communication and implicit bias in racially-discordant patient-provider interactions as they relate to

patient engagement in self-management.

Highlighted Publication

Page 4 PSAD Autumn 2017 Newsletter

The effectiveness of text message-based self-management interventions for poorly-controlled diabetes: A systematic review

Colleagues from New Zealand, Australia, and Canada performed a systematic review of the effective-ness of text messages-based self-management interventions on glycemic control. Eligible studies were randomised controlled trials (RCTs) utilising SMS messages to deliver diabetes self-management inter-ventions to adults with poorly controlled diabetes. This included education, reminders, monitoring, self-care, i.e., nutrition, exercise as well as multifaceted interventions where SMS was a primary com-ponent. Studies were excluded if they examined the use of messages created by a clinician/investigator based on individual clinical judgement or where SMS was used only as a means of real-time communication between provider and patient (i.e., not an automated programme). From the 3922 records identified, seven studies met the inclusion criteria. Three of the studies reported a sig-nificant decrease in HbA1c. Thus, results are mixed. The review is limited by the small number of tri-als. Considering that diabetes management is one of the most investigated areas for the use of mHealth, this study highlights the lack of focus on those with poorly controlled diabetes, a group most in need of intervention.

Dobson, R, Whittaker, R, Pfaeffli Dale, L, Maddison, R. The effectiveness of text message-based self-management inter-ventions for poorly-controlled diabetes: A systematic review DIGITAL HEALTH. First Published November 9, 2017

Maartje de Wit

The team from The Australian Centre for Behavioural Research in Diabetes has launched a new web-

site: https://acbrd.org.au/. Please visit the web-site for a list of their recent publications, conference

presentations, developed resources, and news & views on Australian and international behavioural

diabetes research.

Announcement

New Publications

Bijlsma-Rutte A, Braamse AMJ, van Oppen P, Snoek FJ, Enzlin P, Leusink P, Nijpels G, Elders PJM. Screening for sexual dissatisfaction among people with type 2 diabetes in primary care. J Diabetes Complica-tions. 2017 Aug 4. pii: S1056-8727(17)30645-1. doi: 10.1016/j.jdiacomp.2017.07.020.*Epub ahead of print+

Brouwer A, Nguyen HT, Snoek FJ, van Raalte DH, Beekman ATF, Moll AC, Bremmer MA.Light thera-py: is it safe for the eyes? Acta Psychiatr Scand. 2017 Sep 10. doi: 10.1111/acps.12785. *Epub ahead of print+ Review.

Browne JL, Holmes-Truscott E, Ventura A, Hendrieckx C, Pouwer F, Speight J. Cohort profiles of the cross-sectional and prospective participant groups in the second Diabetes MILES – Australia (MILES-2) study. BMJ Open, 2017; 7:e012926, doi: 10.1136/bmjopen-2016-012926.

Craike MJ, Mosley K, Browne JL, Pouwer F, Speight J. Associations between physical activity and depressive symptoms by weight status among adults with type 2 diabetes: results from Diabetes MILES – Australia. Journal of Physical Activity & Health, 2017; 14(3): 196-202.

Dennicka KJ, Sturta J, Speight J. What is diabe-tes distress and how can we measure it? A narrative review. Journal of Diabetes and Its Complica-tions, 2017; 31(5): 898-911

Dunning T, Speight J, Bennett C. Language, the ‘diabetes restricted code/dialect ’and what it means for people with diabetes and clinicians. The Diabetes Edu-cator, 2017; 43(1): 18-26.

Page 5 PSAD Autumn 2017 Newsletter

Egan AM, Vellinga A, Harreiter J, Simmons D, Desoye G, Corcoy R, Adelantado JM, Devlieger R, Van Assche A, Galjaard S, Damm P, Mathiesen ER, Jensen DM, Andersen L, Lapolla A, Dalfrà MG, Bertolotto A, Mantaj U, Wender-Ozegowska E, Zawiejska A, Hill D, Jelsma JGM, Snoek FJ, Worda C, Bancher-Todesca D, van Poppel MNM, Kautzky-Willer A, Dunne FP; DALI Core Investigator group. Epidemiology of gestational diabe-tes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia. 2017 Jul 12. doi: 10.1007/s00125-017-4353-9. *Epub ahead of print+

Ehrmann D, Schmitt A, Reimer A, Haak T, Kulzer B, Hermanns N. The affective and somatic side of depression: subtypes of depressive symptoms show diametrically opposed associations with glycemic control in people with type 1 diabetes. Acta Diabetologica 2017;54:749-756. doi: 10.1007/s00592-017-1006-x

Eilander MM, de Wit M, Rotteveel J, Aanstoot HJ, Bakker-van Waarde WM, Houdijk EC, Nuboer R, Win-terdijk P, Snoek FJ. Disturbed eating behaviors in adoles-cents with type 1 diabetes. How to screen for yellow flags in clinical practice? Pediatr Diabetes. 2017 Aug;18(5):376-383.

Furler J, O’Neal DN, Speight J, Manski-Nankervis J, Gorelik A, Holmes-Truscott E, Ginnivan LE, Young D, Best J, Patterson E, Liew D, Segal L, May CR, Blackberry I. Supporting insulin initiation in type 2 diabetes in pri-mary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial. BMJ Open, 2017; 7(2): e012926. doi: 10.1136/bmjopen-2016-012926.

Goethals ER, de Wit M, Van Broeck N, Lemiere J, Van Liefferinge D, Böhler S, De Wulf M, Dello E, Laridaen J, Van Hecke L, Van Impe S, Casteels K, Luyckx K. Child and parental executive functioning in type 1 diabetes: Their unique and interactive role toward treatment ad-herence and glycemic control. Pediatr Diabetes. 2017 Jul 30.

New Publications cont.

Page 6 PSAD Autumn 2017 Newsletter

Jelsma JGM, Simmons D, Gobat N, Rollnick S, Blumska K, Jans G, Galjaard S, Desoye G, Corcoy R, Jua-rez F, Kautzky-Willer A, Harreiter J, van Assche A, Devlieger R, Timmerman D, Hill D, Damm P, Mathiesen ER, Wender-Ożegowska E, Zawiejska A, Lapolla A, Dal-frà MG, Del Prato S, Bertolotto A, Dunne F, Jensen DM, Andersen L, Snoek FJ, van Poppel MNM.Is a motiva-tional interviewing based lifestyle intervention for obese pregnant women across Europe implemented as planned? Process evaluation of the DALI study. BMC Pregnancy Childbirth. 2017 Sep 7;17(1):293. doi: 10.1186/s12884-017-1471-9. Jones A, Vallis M, Cooke D, Pouwer F. (2016). Review of research grant allocation to psychosocial studies in diabetes research. Diabetic Medicine, 33(12): 1673-1676 Lake AJ, Browne JL, Rees G, Speight J. Measuring quality of life: the importance of thinking in more than two dimensions. Journal of Diabetes and its Complications, 2017; 31(6): 997-1006. Morrison M, Audehm R, Barry A, Hendrieckx C, Nankervis A, Porter C, Scibilia R, Ross GP. Resources to support preconception care for women with diabe-tes. Diabetes & Primary Care Australia, 2017; 2: 50-3 Narendran, P., Jackson, N., Daley, A., Thomp-son, D., Stokes, K., Greenfield, S., Charlton, M., Curran, M., Solomon, T.P.J., Nouwen, A., Lee., .I., Cooper, A.R., Mostazir, M., Taylor., R.S., Kennedy, A., Andrews, R.C. (2017). Exercise to preserve b-cell function in recent-onset Type 1 diabetes mellitus (EXTOD) – a randomized controlled pilot trial. Diabetic Medicine, DOI: 10.1111/dme.13439. Nouwen, A., Chambers, A., Chechlacz, M, Higgs, S., Blissett, J., Barrett, T.G., Allen, H.A. Micro-structural abnormalities in white and gray matter in obese adolescents with and without type 2 diabetes. NeuroImage: Clinical, 16 (2017) 43–51. Perrin NE, Davies MJ, Robertson N, Snoek FJ,

Khunti K.The prevalence of diabetes-specific emotional

distress in people with Type 2 diabetes: a systematic

review and meta-analysis. Diabet Med. 2017 Aug 11.

doi: 10.1111/dme.13448. *Epub ahead of print+ Re-

view.

Pols AD, van Dijk SE, Bosmans JE, Hoekstra T, van Marwijk HWJ, van Tulder MW, Adriaanse MC. Effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: A pragmatic cluster randomized controlled trial. PLoS One. 2017 Aug 1;12(8):e0181023. PMID: 28763451

. Grabowski D, Andersen TH, Varming A, Ommundsen C, Willaing I. Involvement of family mem-bers in life with type 2 diabetes: Six interconnected prob-lem domains of significance for family health identity and healthcare authenticity. 2017. SAGE Open Medicine. 5(1-9). DOI: 10.1177/2050312117728654 Halliday J, Hendrieckx C, Busija L, Browne J, Nefs G, Pouwer F, Speight J. Validation of the WHO-5 as a first-step screening instrument for depression in adults with diabetes: Results from Diabetes MILES – Austral-ia. Diabetes Research and Clinical Practice, doi: 10.1016/j.diabres.2017.07.005 Hendrieckx C, Hagger V, Jenkins A, Skinner TC, Pouwer F, Speight J. Severe hypoglycemia, impaired awareness of hypoglycemia and self-monitoring in adults with type 1 diabetes: Results of the Diabetes MILES – Australia. Journal of Diabetes and its Complica-tions, 2017; 31(3): 577-582 doi: 10.1016/j.jdiacomp.2016.11.013. Hendrieckx C, Poole LA, Sharifi A, Jayawardene D, Loh MM, Horsburgh JC, Bach LA, Colman PG, Ku-mareswaran K, Jenkins AJ, MacIsaac RJ, Ward GM, Grosman B, Roy A O’Neal DN, Speight J. ‘It is definitely a game changer’: a qualitative study of experiences with in-home overnight closed-loop technology among adults with type 1 diabetes. Diabetes Technology & Thera-py, 2017; 9(7): 410-416 doi: 10.1016/j.jdiacomp.2016.11.013. Herder C, Schmitt A, Budden F, Reimer A, Kulzer B, Roden M, Haak T, Hermanns N. Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes – potential differences by diabetes type and depression scores. Translational Psychiatry 2017; in press. Hilliard M, Hagger V, Hendrieckx C, Anderson B, Trawley S, Jack M, Pouwer F, Skinner T, Speight J. Strengths, risk factors, and resilient outcomes in ado-lescents with type 1 diabetes: results from Diabetes MILES Youth – Australia. Diabetes Care, 2017; 40(7): 849-855. Holmes-Truscott E, Furler J, Speight J, O’Neal D. Predictors of insulin uptake among adults with type 2 diabetes in the Stepping Up Study Journal. Diabetes Re-search and Clinical Practice, 2017; online ahead of print. Holmes-Truscott E, Pouwer F, Speight J. Assessing psychological insulin resistance in type 2 dia-betes: a critical comparison of measures. Current Diabe-tes Reports, 2017; 17 (7): 46.

New Publications cont. Pols AD, Schipper K, Overkamp D, van Dijk SE, Bosmans JE, van Marwijk HW, Adriaanse MC, van Tulder MW. Process evaluation of a stepped-care program to prevent depression in primary care: patients' and practice nurses' experiences. BMC Fam Pract. 2017 Feb 23;18(1):26. PMID: 28231847

Rane K, Gåfvels C. Social work interventions in

Sweden for patients newly diagnosed with type 1 or

type 2 diabetes. Social Work in Health Care 2017, Vol

56, No 8, 700-713.

Rees G, O’Hare F, Saeed M, Sudholz B, Sturrock

B, Xie J, Speight J, Lamoureux E. Problem-solving thera-

py for adults with diabetic retinopathy and diabetes-

specific distress: a pilot randomised controlled tri-

al. BMJ Open Diabetes Research & Care, 2017; 5(1):

e000307, doi: 10.1136/bmjdrc-2016-000307

Reimer, A., Schmitt, A., Ehrmann, D., Kulzer, B.,

& Hermanns, N. (2017). Reduction of diabetes-related

distress predicts improved depressive symptoms: A

secondary analysis of the DIAMOS study. PLoS One, 12

(7), e0181218.

Schmidt CB, Potter van Loon BJ, Kiliç E, Snoek

FJ, Honig A. Validation of a quick screening instrument

for measuring fear of hypoglycaemia in persons with

diabetes. J Diabetes Complications. 2017 Aug; 31(8):

1360-1361. doi: 10.1016/j.jdiacomp.2017.05.009. Epub

2017 May 25. No abstract available.

Schmitt A, Reimer A, Ehrmann D, Kulzer B, Haak

T, Hermanns N. Reduction of depressive symptoms

predicts improved glycaemic control: Secondary results

from the DIAMOS study. Journal of Diabetes and its

Complications 2017; in press. DOI: 10.1016/

j.jdiacomp.2017.08.004

Schmitt A, Reimer A, Hermanns N, Kulzer B,

Ehrmann D, Krichbaum M, Huber J. Haak T. Depression

is linked to hyperglycaemia via suboptimal diabetes self

-management: A cross-sectional mediation analysis.

Journal of Psychosomatic Research 2017;94:17-23. doi:

10.1016/j.jpsychores.2016.12.015

Schnell O, Barnard K, Bergenstal R, Bosi E, Garg

S, Guerci B, Haak T, Hirsch IB, Ji L, Joshi SR, Kamp M,

Laffel L, Mathieu C, Polonsky WH, Snoek F, Home P.

Role of Continuous Glucose Monitoring in Clinical Tri-

als: Recommendations on Reporting. Diabetes Technol

Ther. 2017 Jul;19(7):391-399. doi: 10.1089/

dia.2017.0054. Epub 2017 May 22.

Page 7 PSAD Autumn 2017 Newsletter

Speight J. Letter to editor: Behavioural innova-

tion is key to improving the health of one million Aus-

tralians living with type 2 diabetes. Medical Journal of

Australia, 2017; 206(3): 142.

Speight J. Measuring quality of life: the im-portance of thinking in more than two dimensions. BMJ, 2017; 354:i3816

van Agtmaal MJM, Houben AJHM, Pouwer F,

Stehouwer CDA, Schram MT. Association of Microvascu-

lar Dysfunction with late-life depression. A systematic

review and meta-analysis. 2017. JAMA Psychiatry 74

(7):729-739. doi:10.1001/jamapsychiatry.2017.0984

van Beers CAJ, de Wit M, Kleijer SJ, Geelhoed-

Duijvestijn PH, DeVries JH, Kramer MHH, Diamant M,

Serné EH, Snoek FJ.Continuous Glucose Monitoring in

Patients with Type 1 Diabetes and Impaired Awareness

of Hypoglycemia: Also Effective in Patients with Psycho-

logical Distress? Diabetes Technol Ther. 2017 Aug 24.

doi: 10.1089/dia.2017.0141. *Epub ahead of print+

Vloemans AF, van Beers CAJ, de Wit M, Cleijne

W, Rondags SM, Geelhoed-Duijvestijn PH, Kramer MHH,

Serné EH, Snoek FJ.Keeping safe. Continuous glucose

monitoring (CGM) in persons with Type 1 diabetes and

impaired awareness of hypoglycaemia: a qualitative

study. Diabet Med. 2017 Jul 21. doi: 10.1111/

dme.13429. *Epub ahead of print+

Wieringa TH, de Wit M, Twisk JWR, Snoek FJ.

Does hypoglycaemia affect the improvement in QoL

after the transition to insulin in people with type 2 dia-

betes? J Endocrinol Invest. 2017 Aug 12. doi: 10.1007/

s40618-017-0744-5. *Epub ahead of print+

Wieringa TH, Kunneman M, Rodriguez-Gutierrez

R, Montori VM, de Wit M, Smets EMA, Schoonmade LJ,

Spencer-Bonilla G, Snoek FJ. A systematic review of deci-

sion aids that facilitate elements of shared decision-

making in chronic illnesses: a review protocol. Syst Rev.

2017 Aug 7;6(1):155. doi: 10.1186/s13643-017-0557-9.

Paula M. Trief -Senior Associate Dean for Faculty Affairs & Faculty Development Depts. of Psychiatry &

Medicine SUNY Upstate Medical University has been awarded a grant by NIH- National Institute of

Diabetes, Digestive and Kidney Diseases for the study ‘Behavioral Adherence in Emerging Adults with

Type 2 Diabetes: Ancillary Study’. This is an observational study of "emerging adults" (18-30 years of age)

with type 2 diabetes who are currently enrolled in the TODAY2 trial. In TODAY2, these individuals are

primarily being assessed medically. In this ancillary study, we will follow them from a psychosocial

perspective, specifically looking at factors that predict medication adherence and healthcare usage, both

key to effective self-management, and the relationship of these factors to glycemic control and other

diabetes-related outcomes.

Jacqueline Hugtenburg—Clinical Pharmacology and Pharmacy, VU University Medical Center and

Marcel Adriaanse—PSAD, Health Sciences, Vrije Universiteit Amsterdam have been awarded a grant by

the Netherlands Organisation for Health Research and Development. Primary aim of their study is to im-

prove diabetes medication care in general practices and pharmacies. Hugtenburg and Adriaanse will in-

vestigate the causes of noncompliance, develop a protocol/intervention, and test and evaluate the feasi-

bility and effectiveness in practice. The project is designed in a digital manner within the existing elec-

tronic databases of participating health care providers. The expected outcomes are an improved proto-

col, improved self-management of diabetes medication use by the patient, and enhanced blood glucose

levels on the long term.

Thomas Wieringa - VU Medical Center, Department of Medical Psychology , won a Travel Grant to visit

the Mayo Clinic (Rochester, Minnesota, USA). The Travel Grant project aims to make the Diabetes

Symptom Checklist-revised (DSC-r) useful for clinical practice and bring the DSC-r into the clinical

encounter.

Grants and Funding

Page 8 PSAD Autumn 2017 Newsletter

PSAD Awards

The PSAD Science Award 2018 sponsored by Professor Katharine Barnard

through Barnard Health Research (BHR).

The PSAD Science Award aims to stimulate and

promote high-quality research papers in the

field of diabetes. The PSAD Award will be

granted to the first author of the best-submitted

paper in the area of Diabetes Psychology. The

winner will be announced during the annual PSAD

Scientific Meeting Verona 2018. The recipient will

be invited to present his/her research at this

meeting. Further details will be sent shortly.

The PSAD Science Award 2018 is generously

sponsored with 500 £.

Page 9 PSAD Autumn 2017 Newsletter

PSAD has now an official tweet account!

PSAD!

PSAD have a twitter account, and we would like hear from you!!

We would like to tweet about your achievements, news, publications, research, and awards in each of our countries!

You can send an email to Juan Albertorio (jna8@cdc.gov) and we can tweet or retweet your news!

You can follow us as twitter as well at : https://twitter.com/PSAD_Group

We’re on the web at

http://www.psad-easd.eu/

Twitter Account

https://twitter.com/PSAD_Group

PSAD Scientific Spring Meeting 2018

3rd-5th May

Verona , Italy

Page 10 PSAD Autumn 2017 Newsletter

PSAD Study Group